TSC–LAM | Sporadic LAM | |||
FEV1 | DLCO | FEV1¶ | DLCO | |
Patients n | 73 | 73 | 319 | 317 |
Decline in % predicted | ||||
>10% | 1 (1.3) | 4 (5.4) | 11 (3.4) | 14 (4.3) |
8–10% | 3 (4.1) | 2 (2.7) | 9 (2.8) | 10 (3.1) |
6–8% | 5 (6.8) | 8 (10.9) | 19 (5.9) | 12 (3.7) |
4–6% | 2 (2.7) | 4 (5.4) | 32 (10.0) | 38 (11.9) |
2–4% | 13 (17.8) | 15 (20.5) | 87 (27.2) | 84 (26.3) |
0–2% | 31 (42.4) | 27 (36.9) | 95 (29.7) | 90 (28.2) |